SUSMED,Inc. develops and sells therapeutic applications in Japan. It operates through DTx product business, and DTx platform business segments. The company develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. It also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, the company offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Frequently asked questions
What sector does SUSMEDInc. (4263) operate in?
SUSMEDInc. belongs to the Healthcare sector and operates in the Health Information Services industry.
What is SUSMEDInc. (4263) current stock price?
As of the latest data, SUSMEDInc. stock price is ¥548, with a previous close of ¥530. SUSMEDInc. gained ¥18 in the last trading session, representing a 3.4% increase.
What is SUSMEDInc. (4263) current market capitalization?
SUSMEDInc. market cap is approximately 9.24 billion.
What is SUSMEDInc. (4263) Earnings Per Share (EPS)?
The trailing EPS is -¥15, and the forward EPS is ¥17.
What is SUSMEDInc. (4263) EBITDA?
SUSMEDInc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 19.20 million.
Does SUSMEDInc. (4263) pay dividends?
No. SUSMEDInc. does not pay a dividend.
What is SUSMEDInc. (4263) beta (volatility) score?
SUSMEDInc. has a beta of 1.187, meaning its volatility is roughly in line with the market.